Max Petersen on the Role of Unified Platforms in Digital Laboratory Transformation
Max Petersen, Associate VP at Dotmatics, emphasizes that unified platforms integrating data across disciplines and contextualizing experiments through workflows and roles are essential for overcoming data quality challenges in digital laboratory transformation, enabling deeper insights and faster innovation in data-driven R&D.
A Digital Journey
September 2021 | Sophia Ktori examines the role software companies play in driving digital transformation in the laboratory.
A major challenge for data-driven R&D is the lack of high-quality data. While accurate sample, analytical, and physical characterization data may exist, they are generally not helpful when analyzing why or how a specific experiment contributed to the overall success of an innovation project. This can only be achieved with a unified platform approach that links data from all disciplines together and contextualizes experiments by implementing workflows and roles. This provides data insights that are otherwise impossible and helps our customers to innovate faster.
– Max Petersen, Associate VP of Chemicals & Materials Marketing at Dotmatics
Related
Data-Driven R&D in Chemicals & Materials: Why an Open Platform is Essential
The webinar titled "Data-Driven R&D in Chemicals & Materials: Why an Open Platform is Essential," presented by Max Petersen of Dotmatics, discusses how a unified, open scientific data platform enhances interoperability among existing R&D IT systems, supports diverse scientific workflows, and empowers researchers in chemicals and materials industries to tackle challenges like sustainability by enabling comprehensive, strategic data access.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Max Petersen on Digitalization in Chemical R&D
Max Petersen explains that digitalization, particularly data-driven R&D using AI techniques like unsupervised learning, is essential for accelerating innovation and addressing global challenges such as sustainability and climate change in the specialty chemicals industry.
Dotmatics Electronic Laboratory Notebook (ELN)
Dotmatics Electronic Laboratory Notebook (ELN) is a secure, cloud-hosted, and intuitive virtual notebook designed by scientists to streamline capturing, storing, searching, and sharing diverse scientific experiments and data types across disciplines, featuring flexible protocols, intelligent dashboards, integration with Dotmatics applications and third-party databases, and support for internal and external collaboration to enhance productivity and data-driven decision making.
Reasonable Expectations, Clean Data, Collaboration: The Three Keys to AI in Drug Discovery
The article explains that while AI and machine learning have long been used in drug discovery, recent hype and massive investments have led to unrealistic expectations, emphasizing that success depends on setting reasonable goals, ensuring clean and abundant data, and fostering collaboration, as most AI-driven drug candidates remain in early development stages and face complex biological and practical challenges.